Original Research
Accepted on 06 Nov 2025
Efficacy of neoadjuvant pembrolizumab combined with paclitaxel and cisplatin in locally advanced oropharyngeal and hypopharyngeal squamous cell carcinoma: a retrospective study
in Cancer Immunity and Immunotherapy